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Abstract: Phaeohyphomycosis is an uncommon mycotic infection caused 
by dematiaceous fungi. We report a 53-year-old male who presented with 
phaeohyphomycosis on his upper extremities, 6 months after renal 
transplantation. Biopsy revealed pigmented moniliform hyphae and 
cultures grew Exophiala oligosperma. The lesions completely resolved 
after 3 months of treatment with posaconazole. 
 
Keywords: Phaeohyphomycosis, Exophiala, oligosperma, Dematiaceous, 
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Introduction 
Phaeohyphomycosis is an uncommon infection that is 
caused by an increasing number of dematiaceous, or 
pigmented fungi. Infections caused by these pigmented 
moulds are thought to be opportunistic fungal diseases. 
The pigment is due to the presence of melanin in their 
cell walls. Infections can either be localized to 
subcutaneous tissue, or they can progress to 
disseminated disease, which can affect solid organs, such 
as the lungs, as well as the CNS (Murray et al., 2012). 
Post-transplant mycoses are mostly comprised of 
mycelial organisms (Schieffelin et al., 2014). There are a 
large number of these dark genera that cause human 
infection, however, the most common include: Alternaria, 
Bipolaris, Cladosporium, Curvularia, Exophiala and 
Exserohilum species (Murray et al., 2012). 
Phaeohyphomycosis typically presents as a localized 
subcutaneous or deep-seated infection; commonly as a 
cyst or abscess (Pai et al., 2013). 
These opportunistic fungal infections are becoming 
progressively more relevant to post-transplant patients. 
Fungal infections caused by filamentous fungi make up a 
large proportion of fungal infections and non-Aspergillus 
species, including those genera inciting 
phaeohyphomycosis, make up 27% of invasive mycelial 
fungal infections (Schieffelin et al., 2014). It is thought 
that as the number of solid organ transplant recipients 
continues to increase, as will the incidence of 
phaeohyphomycosis in these immunocompromised 
patients (Schieffelin et al., 2014).  
Case Report 
A 53-year-old retired male with a past medical 
history of adult polycystic kidney disease, status post 
kidney transplant 7 years prior and a deceased donor 
kidney transplant 6 months prior, was incidentally found 
to have erythematous, non-pruritic, papular lesions on 
his upper extremities bilaterally, during an admission for 
Superior Vena Cava (SVC) syndrome (Fig. 1, 
Supplementary Data). He did not recall any trauma to his 
arms. He received thymoglobulin and hydrocortisone for 
induction and was continued on tacrolimus and 
mycophenolate for his recent transplant. He was then 
transitioned to cyclosporine and ultimately to belatacept 
and prednisone for maintenance therapy. His vital signs 
were stable and he remained afebrile throughout the 
admission. Upon examination, he was found to have 
erythematous slightly tender nodules, some with central 
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vesicles, on bilateral upper extremities. No regional 
lymphadenopathy was appreciated. Routine labs 
including complete blood count, basic metabolic panel 
and hepatic function tests were within normal limits, 
in the context of his recent transplant. However, due 
to the patient’s immunocompromised state, these 
lesions raised clinical suspicion for possible infection 
and dermatology was consulted. A punch biopsy and 
tissue culture were performed. Histopathology 
revealed a suppurative granuloma in the dermis 
containing slightly pigmented moniliform fungal 
hyphae (Fig. 2 and 3, Supplementary Data). Periodic 
acid-Schiff (PAS) and Grocott’s Methenamine Silver 
(GMS) staining were positive, confirming fungal 
infection (Fig. 4, Supplementary Data). Acid Fast 
Bacilli (AFB) stain was performed, which was 
negative for mycobacteria. Initial tissue cultures were 
positive for few mold-like fungi and gram stains were 
negative. The presumptive diagnosis of 
phaeohyphomycosis was made at this time. Further 
identification of the isolate and antifungal susceptibility 
testing were performed at the Fungus Testing Laboratory 
at the University of Texas Health Science Center at San 
Antonio (UTHSCSA), which revealed Exophiala 
oligosperma as the causative pathogen. MRI of the brain 
and CT scan of the sinuses and chest were all 
subsequently ordered to evaluate for disseminated 
infection. All imaging and blood cultures were negative 
and the diagnosis of subcutaneous phaeohyphomycosis 
was confirmed. The patient was then started on a course of 
posaconazole. His posaconazole level was maintained in 
therapeutic range throughout the admission and he 
remained compliant upon discharge. The lesions appeared 
to improve after 10 days of treatment, with marked 
improvement after 2 months of therapy. The lesions have 
completely resolved after 3 months of treatment. 
 
 
 
Fig. 1. Multiple erythematous nodular lesions on the posterior 
aspect of his right forearm 
 
 
Fig. 2. Skin biopsy shows the presence of suppurative 
granulomas in the dermis. H and E stain, ×20 
 
 
 
Fig. 3. Scattered light brown fungal organisms (indicated by 
arrow) are vaguely visible in the background of 
granulomas. H and E stain, ×40 
 
Mycology 
The isolate was accessioned into the Fungus Testing 
Laboratory collection as UTHSCSA DI15-4. Colonies 
on Potato Flakes Agar (PFA) prepared in-house were 
olivaceous to black and initially mucoid, becoming 
velvety after 12 days of incubation at 25°C (Fig. 5A, 
Supplementary Data). Microscopic observations on a 
PFA slide culture under the same conditions revealed 
both annellated yeast cells and conidia. Annelloconidia 
were produced from relatively short, inflated 
conidiogenous cells, as well as from intercalary loci. 
(Fig. 5B-C, Supplementary Data). For molecular 
identification, a portion of the cultured isolate was 
suspended in Buffer G2 (Qiagen, Valencia, CA) 
followed by lysing in a bead beater instrument (BioSpec 
Products, Inc., Barlesville, OK). Proteinase K was added 
and the samples were incubated at 56°C for one hour. 
After incubation, the DNA was extracted using the EZ1 
DNA tissue kit on the BioRobot EZ1 instrument 
(Qiagen) according to the manufacturers instructions. 
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Fig. 4. The presence of many fungal organisms is highlighted 
by PAS stain. X 40 
 
 
 
Fig. 5.  A. Macroscopic morphology of E. oligosperma after 12 
days incubation on PFA at 25°C. B and C. Microscopic 
features of E. oligosperma on a PFA slide culture after 
12 days incubation at 25°C showing annelloconidia 
formed from medium-length annellides (dark arrow) as 
well as from conidiogenous loci along the sides of the 
hyphae (light arrow) 
 
Extracted DNA was used for PCR amplification of 
ITS and D1/D2 regions as described (Romanelli et al., 
2010). PCR products were then sequenced using the 
ITS1 and ITS4 primers as well as NL1 and NL4 
primers at the UTHSCSA Molecular Diagnostics 
Laboratory (White et al., 1990). Sequences were 
assembled and analyzed using DNASTAR SeqMan 
Pro version 9.1 (DNASTAR, Inc., Madison, WI) and 
queried in GenBank using the BLASTn algorithm 
available on the NCBI site (www.ncbi.nlm.nih.gov) 
and were also compared to those available in the 
CBS-KNAW Fungal Biodiversity Centre database 
(www.cbs.knaw.nl). The ITS sequence showed 100% 
identity to both E. oligosperma (GenBank Accession 
No. AB480204.1) and E. jeanselmei (GenBank 
Accession No. AJ866273.1), while the D1/D2 
sequence showed 100% identity with E. jeanselmei 
(GenBank Accession No. KC311520.1). By barcode 
analysis, there was 100% match with E. oligosperma 
(UTHSC 91-870) (Heinrichs et al., 2012). Based on 
the above, the isolate was identified as E. 
oligosperma. The ITS and D1/D2 nucleotide 
sequences have been deposited into GenBank under 
accession numbers KP938216 and KP938217, 
respectively. Antifungal susceptibility testing was 
performed according to the methods described in the 
Clinical and Laboratory Standards Instituted (CLSI) M38-
A2 document for filamentous fungi (CLSI, 2008). The 
Minimum Inhibitory Concentration (MIC) for amphotericin 
B was 2 µg Ml
−1
, 8 µg Ml
−1
 for fluconazole and 0.25 µg 
Ml
−1
 each for posaconazole and voriconazole. 
Discussion 
E. oligosperma was first described in 2003 by De 
Hoog et al. (2003) by sequencing of its ribosomal 
DNA. Exophiala species are environmental fungi that 
are associated with decaying wood and soil organic 
wastes. E. jeanselmei is the most frequently cited of 
the Exophiala species as a human pathogen, however 
sequence data has subsequently shown that E. 
jeanselmei is a species complex and that many of 
these case reports would represent other species if 
characterized at the molecular level. The most 
common clinically relevant species in the United 
States is E. dermatitidis (Zeng et al., 2007). Other 
species such as E. moniliae, E. oligosperma and E. 
spinifera have been implicated as well (Zeng et al., 2007). 
Clinical manifestations for this species include 
mycetoma, localized cutaneous infections, 
subcutaneous cysts, endocarditis, and cerebral and 
disseminated infections (UA, 2001). The cutaneous 
manifestations are nonspecific, therefore it is 
important to have a high index of suspicion for fungal 
infection in order for early diagnosis.  
Phaeohyphomycosis is most commonly diagnosed in 
immunocompromised patients, however, there have been 
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reported cases of infection in immunocompetent patients; 
including a case reported by Venkateshwar et al. (2014). 
Over past 12 years there have been a handful of 
infections with E. oligosperma, including a case 
reported by Rimawi et al. (2013) that describes a 
patient with a 10-year history of lupus and history of 
severe asthma, taking mycophenolate and 
methylprednisolone, who was successfully treated for 
E. oligosperma infection with a 3 month course of 
voriconazole (Rimawi et al., 2013). The included 
literature review noted 6 other reported cases of E. 
oligosperma infection that were susceptible to 
voriconazole and included 1 renal transplant patient 
reported by Gonzalez-Lopez et al (2007). This renal 
transplant patient presented with phaeohyphomycosis 
7 years after transplantation and was successfully 
treated with a 3-month course of itraconazole; with 
full resolution (Gonzalez-Lopez et al., 2007). The 
Gonzalez-Lopez et al. (2007) case is similar to ours, 
as the patient was immunosuppressed with 
mycophenolate, prednisone, and tacrolimus. However, 
our patient presented within 6 months of 
transplantation. Our patient received higher doses of 
immunosuppressive therapy; which may have been a 
contributing factor to his earlier development of 
phaeohyphomycosis in the postoperative period. A 
summary of previously reported skin infections with E. 
oligosperma is shown (Table 1) (Bossler et al., 2003; 
Tokuhisa et al., 2011; Kan et al., 2013; Sato and 
Yaguchi, 2013; Fukai et al., 2013). 
Optimum treatment has been thought to be surgical 
excision and anti-fungal therapy; although there have 
been reports suggesting local hyperthermia as an 
effective treatment as well (Fukai et al., 2013). 
Surgical excision is typically reserved for those 
patients who have solitary lesions. As our patient had 
multiple nodules, we decided systemic anti-fungal 
therapy was the best option for treatment. 
Voriconazole and itraconazole have had the best 
record for treatment; however, we demonstrate that 
posaconazole is effective as well. Although 
susceptibility was ordered, we did not obtain it before 
starting him on posaconazole. Since he had a 
favorable response to the therapy, he was continued 
on a 3-month course. If there had been evidence of 
disseminated infection, the plan was for combination 
therapy with both posaconazole and amphoteracin B. 
To our knowledge, this is the first case of 
subcutaneous E. oligosperma infection that has been 
successfully treated with posaconazole. 
 
Table 1. Summary of previously reported cases of skin infections due to E. oligosperma 
Reference Age Gender Relevant Duration of Site Presentation Treatment 
    History Treatment 
Bossler et al. 62 M Wegener’s  8 months Left elbow Painless swelling Intrabursal injection  
(2003)   granulomatosis   in left elbow of amphotericin 
Gonzalez-Lopez 72 F Renal  3 months Right leg Multiple subcutaneous Oral itraconazole  
et al. (2007)   transplantation   nodules 
Tokuhisa et al. 57 F None 1 year Left cheek Slightly pruritic, Partial surgical  
(2011)      hyperkeratotic,  excision and topical 
      erythematous lesion terbinafine cream 
Kan et al. 71 F Wegener’s  1 year Left forearm Multiple erythematous Oral voriconazole   
(2013)   granulomatosis   subcutaneous nodules → oral itraconazole 
      with pus discharge surgical excision 
Sato et al. 80 F Takayasu’s 2 months Right cheek Hyperkeratotic, red Thermotherapy,   
(2013)   arteritis   -brown papule potassium iodide, 
       surgical excision,  
       oral itraconazole 
Fukai et al. 58 F Sjogren’s  4 months Left hand Multiple subcutaneous Oral itraconazole → 
(2013)   syndrome   nodules and abscesses local hyperthermia 
Rimawi et al. 50 F Systemic lupus  3 months Both legs Reddish-pink, “rubbery- Oral voriconazole 
(2013)   erythematosis   like” subcutaneous nodules 
Venkateshwar 38 M None  Right elbow Non-tender, soft,  Surgical excision  
et al. (2014)      mobile nodule 
This report 53 M Renal  3 months Both arms Multiple erythematous Oral posaconazole 
   Transplantation   cutaneous nodules with 
      central vesicles 
Asaph C Levy et al. / American Journal of Infectious Diseases 2015, 11 (1): 15.19 
DOI: 10.3844/ajidsp.2015.15.19 
 
19 
Author Contributions 
EM, AL, SR, HR: Conceptualization. AL, SR, DS, 
KB, SC, DH, NW, HF, JL: Manuscript Writing. DS, 
NW, HF, JL: Mycology. AL, SR, DS, MB, NA, EM, 
HR: Manuscript Editing. 
SC: Pathology. 
Acknowledgment 
We would like to acknowledge both North Shore-LIJ 
Health System and the University of Texas Health 
Science Center at San Antonio for their collaboration 
both with successfully treating this patient, as well as 
writing this case report. 
Ethics 
Patient consent was obtained for this case report. As 
a result, we do not anticipate any ethical issues to arise 
after publication of this manuscript. 
References 
Murray, P., K. Rosenthal and M. Pfaller, 2012. 
Opportunistic Mycoses: Phaeohyphomycosis. 
Murray: Medical Microbiology, 7th Edn., Elsevier 
Health Sciences, London, pp: 694-95. 
Schieffelin, J.S., J.B. Garcia-Diaz, G.E. Loss, E.N. 
Beckman and R.A. Keller et al., 2014. 
Phaeohyphomycosis fungal infections in solid organ 
transplant recipients: Clinical presentation, 
pathology and treatment. Transplant Infectious 
Disease, 16: 270-278. DOI: 10.1111/tid.12197 
Pai, V.V., K.N. Naveen, K. Hanumanthayya and U.S. 
Dinesh, 2013. Subcutaneous Pheohyphomycosis 
presenting as a innocuous pustule. Indian J. 
Dermatol.., 58: 159-159. 
 DOI: 10.4103/0019-5154.108083  
Romanelli, A.M., D.A. Sutton, E.H. Thompson, M.G. 
Rinaldi and B.L. Wickes, 2010. Sequence-based 
identification of filamentous basidiomycetous fungi 
from clinical specimens: A cautionary note. J. Clinical 
Microbiol., 48: 741-752. DOI: 10.1128/JCM.01948-09 
White, T.J., T.D. Bruns, S.B. Lee and J.W. Taylor, 1990. 
Amplification and Direct Sequencing of Fungal 
Ribosomal RNA Genes for Phylogenetics. In: PCR 
Protocols: A Guide to Methods and Applications, 
Innis, M.A., D.H. Gelfand, J.J. Sninsky, T.J. White, 
(Edn.), Academic Press, Inc., New York; pp: 315-322. 
Heinrichs, G., G.S. De Hoog and G. Haase, 2012. 
Barcode identifiers as a practical tool for reliable 
species assignment of medically important black 
yeast species. J. Clinical Microbiol., 50: 3023-3030. 
DOI: 10.1128/JCM.00574-12 
CLSI, 2008. Reference Method for Broth Dilution 
Antifungal Susceptibility Testing of Filamentous 
Fungi. Approved standard. 2nd Edn., Clinical and 
Laboratory Standards Institute, Wayne, Pennsylvania. 
De Hoog, G.S., V. Vicente, R.B. Caligiorne, S. 
Kantarcioglu and K. Tintelnot et al., 2003. Species 
diversity and polymorphism in the exophiala 
spinifera clade containing opportunistic black yeast-
like fungi. J. Clinical Microbiol., 41: 4767-4778. 
DOI: 10.1128/JCM.41.10.4767-4778.2003 
Zeng, J.S., D.A. Sutton, A.W. Fothergill, M.G. Rinaldi 
and M.J. Harrak et al., 2007. Spectrum of clinically 
relevant Exophiala species in the United States. J. 
Clinical Microbiol., 45: 3713-20. 
 DOI: 10.1128/JCM.02012-06 
UA, 2001. Exophiala Jeanselmei. The University of 
Adelaide. 
Venkateshwar, S., M.M. Ambroise, G.J. Asir, N. Mudhigeti 
and A. Ramdas et al., 2014. A rare case report of 
subcutaneous phaeohyphomycotic cyst caused by 
exophiala oligosperma in an immunocompetent host 
with literature review. Mycopathologia, 178: 117-21. 
DOI: 10.1007/s11046-014-9762-4 
Rimawi, B., R.H. Rimawi, M. Mirdamadi, L.L. Steed and 
R. Marchell et al., 2013. A case of exophiala 
oligosperma successfully treated with voriconazole. 
Med. Mycol. Case Reports, 2: 144-147. 
 DOI: 10.1016/j.mmcr.2013.08.003  
Gonzalez-Lopez, M., R. Salesa, M.C. González-Vela, H. 
Fernández-Llaca and J.F. Val-Bernal et al., 2007. 
Subcutaneous phaeohyphomycosis caused by 
exophiala oligosperma in a renal transplant 
recipient. British J. Dermatol., 156: 762-4. 
 DOI: 10.1111/j.1365-2133.2006.07732.x 
Bossler, A.D., S.S. Richter, A.J. Chavez, S.A. 
Vogelgesang and D.A. Sutton et al., 2003. 
Exophiala oligosperma causing olecranon Bursitis. 
J. Clinical Microbiol., 41: 4779-82. 
 DOI: 10.1128/JCM.41.10.4779-4782.2003 
Tokuhisa, Y., Y. Hagiya, M. Hiruma and K. Nishimura, 
2011. Phaeohyphomycosis of the face caused by 
exophiala oligosperma. Mycoses, 54: 240-243.  
 DOI: 10.1111/j.1439-0507.2009.01845.x 
Kan, T., S. Takahagi, A. Kamegashira, H. Ooiwa and T. 
Yaguchi et al., 2013. Disseminated subcutaneous 
phaeohyphomycosis caused by exophiala 
oligosperma in a patient with wegener’s 
granulomatosis. Acta dermato-venereologica, 93: 
356-357. DOI: 10.2340/00015555-1451 
Sato, T. and T. Yaguchi, 2013. A case of 
phaeohyphomycosis of the face caused by exophiala 
oligosperma in an immunocompromised host. J. 
German Society Dermatol., 11: 1087-89. 
 DOI: 10.1111/ddg.12158 
Fukai, T., M. Hiruma, Y. Ogawa, S. Ikeda and H. Ikeda 
et al., 2013. A case of phaeohyphomycosis caused 
by exophiala oligosperma successfully treated with 
local hyperthermia. Med. Mycol. J., 54: 297-301. 
DOI: 10.3314/mmj.54.297 
